Lataa...
Epoetin-associated pure red cell aplasia: past, present, and future considerations
BACKGROUND: Since 1988, millions of patients have received epoetin products intravenously (IV) and subcutaneously. In 1998, epoetin-associated pure red cell aplasia (PRCA) was first reported and causation was attributed to formulations without human serum albumin (HSA), subcutaneous administration,...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2730535/ https://ncbi.nlm.nih.gov/pubmed/18482185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2008.01749.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|